Archive · 20 Aug 2025
Dominari Holdings' Rise: Trump's Financial Dealmakers
A company that used to work on medicine, called Dominari, changed its focus to help Donald Trump and his family with their money and business deals.
They set up an office in Trump Tower and started advising Trump's sons, Eric and Don Jr., on investments.
Dominari invested in things like bitcoin and helped raise money for a bitcoin mining company.
Eric and Don Jr. also put money into Dominari, which helped the company grow.
Dominari has worked with people in the crypto world on deals and is currently involved in a plan to buy a manufacturing company.
Dominari Holdings, formerly AIkido Pharma, shifted from biotech to finance, becoming a financial partner for the Trump family.
The company secured office space in Trump Tower and began advising Eric and Donald Trump Jr. on investments.
Dominari invested in bitcoin ETFs and co-invested with the Trumps in American Bitcoin, a mining company.
Eric and Donald Trump Jr. invested in Dominari, becoming advisors and major shareholders, boosting the company's stock.
Dominari has facilitated deals involving crypto figures like Justin Sun and is working on a SPAC to buy a US manufacturer.
- Who
- Dominari Holdings, led by CEO Anthony Hayes and Wall Street veteran Kyle Wool, is working closely with Donald Trump and his sons, Eric and Donald Jr.
- What
- Dominari Holdings, a company formerly in biotech, transitioned into finance and became a key financial partner for the Trump family, facilitating various investments and deals.
- When
- Dominari's shift towards finance and partnership with the Trumps began after the January 6 riots and gained momentum in recent years.
- Where
- The company operates from Trump Tower and is involved in deals across the financial and crypto sectors.
- Why
- Dominari sought to capitalize on business opportunities arising from Trump's political comeback and the Trump family's expanding business ventures.
Criticisms
Proponents
Financial Ties and Influence
Criticisms
Critics may raise concerns about potential conflicts of interest and undue influence due to the close financial ties between Dominari and the Trump family.
Proponents
Proponents might argue that Dominari's success is due to sound financial strategies and seizing opportunities, without necessarily implying any unethical conduct.
- Company Name
- Dominari Holdings (formerly AIkido Pharma)
- Initial Revenue (2023)
- $2 million
- Net Loss (2023)
- $23 million
- Accumulated Deficit (end of 2023)
- $223 million
- Eric and Don Jr. Investment
- $1 million each
- American Bitcoin Fees
- $4.8 million
- Justin Sun Investment in WLF
- $75 million
- Justin Sun Investment in Trump Memecoin
- $20 million